Evidence map›Paper›PMID 26788255›Full record

ArticleOxidative medicine and cellular longevity2016

Cholesterol Enhances the Toxic Effect of Ethanol and Acetaldehyde in Primary Mouse Hepatocytes.

Anayelly López-Islas, Victoria Chagoya-Hazas, Benjamin Pérez-Aguilar, Mayrel Palestino-Domínguez, Verónica Souza, Roxana U Miranda, Leticia Bucio, Luis Enrique Gómez-Quiroz, María-Concepción Gutiérrez-Ruiz

Open access · hybridAbstract read
In one paragraph

Article in Oxidative medicine and cellular longevity, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Dietary cholesterol in alcohol-associated liver disease.Immunometabolism (Cobham, Surrey) · 2023
    Review
  3. Article
  4. Article
  5. Sphingolipids and the link between alcohol and cancer.Chemico-biological interactions · 2020
    Review
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Anayelly López-IslasDepartamento de Ciencias de la Salud, Universidad Autónoma Metropolitana Iztapalapa, 09340 México, DF, Mexico.
Victoria Chagoya-HazasInstituto de Fisiología Celular, Universidad Nacional Autónoma de México, 04510 México, DF, Mexico.
Benjamin Pérez-AguilarDepartamento de Ciencias de la Salud, Universidad Autónoma Metropolitana Iztapalapa, 09340 México, DF, Mexico.
Mayrel Palestino-DomínguezDepartamento de Ciencias de la Salud, Universidad Autónoma Metropolitana Iztapalapa, 09340 México, DF, Mexico.
Verónica SouzaDepartamento de Ciencias de la Salud, Universidad Autónoma Metropolitana Iztapalapa, 09340 México, DF, Mexico; Red Fisiopatología de las Enfermedades Hepáticas, PRODEP-SEP, México, DF, Mexico.
Roxana U MirandaDepartamento de Ciencias de la Salud, Universidad Autónoma Metropolitana Iztapalapa, 09340 México, DF, Mexico; Red Fisiopatología de las Enfermedades Hepáticas, PRODEP-SEP, México, DF, Mexico.
Leticia BucioDepartamento de Ciencias de la Salud, Universidad Autónoma Metropolitana Iztapalapa, 09340 México, DF, Mexico; Red Fisiopatología de las Enfermedades Hepáticas, PRODEP-SEP, México, DF, Mexico.
Luis Enrique Gómez-QuirozDepartamento de Ciencias de la Salud, Universidad Autónoma Metropolitana Iztapalapa, 09340 México, DF, Mexico; Red Fisiopatología de las Enfermedades Hepáticas, PRODEP-SEP, México, DF, Mexico.
María-Concepción Gutiérrez-RuizDepartamento de Ciencias de la Salud, Universidad Autónoma Metropolitana Iztapalapa, 09340 México, DF, Mexico; Red Fisiopatología de las Enfermedades Hepáticas, PRODEP-SEP, México, DF, Mexico.
Universidad Autónoma Metropolitana · MXCentro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas · ESUniversidad Nacional Autónoma de México · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Obesity and alcohol consumption are risk factors for hepatic steatosis, and both commonly coexist. Our objective was to evaluate the effect of ethanol and acetaldehyde on primary hepatocytes obtained from mice fed for two days with a high cholesterol (HC) diet. HC hepatocytes increased lipid and cholesterol content. HC diet sensitized hepatocytes to the toxic effect of ethanol and acetaldehyde. Cyp2E1 content increased with HC diet, as well as in those treated with ethanol or acetaldehyde, while the activity of this enzyme determined in microsomes increased in the HC and in all ethanol treated hepatocytes, HC and CW. Oxidized proteins were increased in the HC cultures treated or not with the toxins. Transmission electron microscopy showed endoplasmic reticulum (ER) stress and megamitochondria in hepatocytes treated with ethanol as in HC and the ethanol HC treated hepatocytes. ER stress determined by PERK content was increased in ethanol treated hepatocytes from HC mice and CW. Nuclear translocation of ATF6 was observed in HC hepatocytes treated with ethanol, results that indicate that lipids overload and ethanol treatment favor ER stress. Oxidative stress, ER stress, and mitochondrial damage underlie potential mechanisms for increased damage in steatotic hepatocyte treated with ethanol.

Indexed as

AcetaldehydeAnimalsCells, CulturedCell ShapeCholesterolCytochrome P-450 CYP2E1Diet, High-FatEndoplasmic Reticulum StressEthanolHepatocytesLipidsMaleMice, Inbred C57BLOxidative StressAcetaldehydeCholesterolCytochrome P-450 CYP2E1EthanolLipids

Identifiers

PMID26788255
PMCPMC4691636
OpenAlexW2287346268

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.